Loading...
IFI30 Polyclonal Antibody

27859

IFI30 Polyclonal Antibody

IFI30 Polyclonal Antibody (catalogue number 27859) is a rabbit-derived primary antibody validated for Western blot, reactive with Human samples. It targets Gamma-interferon-inducible lysosomal thiol reductase (IFI30): Lysosomal thiol reductase that catalyzes protein disulfide bonds reduction. Supplied in 2 pack sizes, from 50ul at ₪1,260.38 to 100ul at ₪1,790.64; the final price is confirmed on your quote and the lot certificate of analysis ships with the order.

Primary AntibodyHostRabbit
Host / source
Rabbit
Reactivity
Human
Applications
Western blot
UniProt ID
P13284
Gene
IFI30
Target organism
Homo sapiens
Catalogue number
27859
Brand
LABO Scientific
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.

Target background

Target: Gamma-interferon-inducible lysosomal thiol reductase (IFI30) · Homo sapiens

Lysosomal thiol reductase that catalyzes protein disulfide bonds reduction. Plays an important role in antigen processing and presentation, of namely both major histocompatibility complex (MHC) class I- and class II-restricted antigen by reducing the disulfide bonds of endocytosed proteins and facilitating their unfolding and optimal degradation.

Subcellular location: Secreted; Lysosome

Tissue specificity: Expressed constitutively in antigen-presenting cells

Sequence length: 250 aa · 27964 Da

Protein background from UniProtKB, licensed under CC BY 4.0. Describes the target antigen, not this product.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Storage
Store at -20°C for long term preservation (recommended). Store at 4°C for short term use.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.